Daiwa Securities Group
PTLA

Daiwa Securities Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Daiwa Securities Group’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-439
Closed -$3K – 1263
2020
Q2 		$3K Hold
439
– – ﹤0.01% 1153
2020
Q1 		$3K Hold
439
– – ﹤0.01% 1152
2019
Q4 		$10K Sell
439
-55
-11% -$1.52K ﹤0.01% 1069
2019
Q3 		$13K Buy
494
+72
+17% +$2.02K ﹤0.01% 1022
2019
Q2 		$11K Hold
422
– – ﹤0.01% 1053
2019
Q1 		$15K Buy
422
+61
+17% +$1.76K ﹤0.01% 1008
2018
Q4 		$7K Hold
361
– – ﹤0.01% 1035
2018
Q3 		$10K Hold
361
– – ﹤0.01% 1043
2018
Q2 		$14K Hold
361
– – ﹤0.01% 1033
2018
Q1 		$12K Buy
+361
New +$15.8K ﹤0.01% 1023

Daiwa Securities Group's PTLA Position: Q3 2020 in Review

Daiwa Securities Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 439 shares — an estimated $3K sold.

Daiwa Securities Group first reported a position in PTLA in Q1 2018 and held it in 10 quarters. The position peaked at $15K in Q1 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Daiwa Securities Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Daiwa Securities Group sold 439 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3K.
  • Daiwa Securities Group first reported a position in Portola Pharmaceuticals, Inc. in Q1 2018 and held it in 10 quarters.
  • Daiwa Securities Group's Portola Pharmaceuticals, Inc. position peaked at $15K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Daiwa Securities Group's 13F filing for Q3 2020, filed 2 Nov 2020.